BIOTIME FORM 8-K FEBRUARY 6, 2009

Company

Lineage Cell Therapeutics, Inc.

Filed

February 12, 2009

Period of Report

February 6, 2009

Accession Number

0000876343-09-000006

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →